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Preparation and physico-chemical characterization of matrix pellets 
containing APIs with different solubility via extrusion process 
Abstract: In this study a multiparticulate matrix system was produced, containing 
two different APIs: enalapril-maleate and hydrochlorothiazide. The critical 
control points of the process were investigated by means of factorial design. 
Besides the generally used microcrystalline cellulose, ethylcellulose was used as 
matrix former to achieve modified drug release ensured by diffusion. The matrix 
pellets were made by extrusion-spheronization using a twin-screw extruder. 
Some pellet properties (aspect ratio, 10% interval fraction, hardness, deformation 
process) were determined. The aim of our study was to investigate how the two 
different APIs with different solubility and particle size influence the process. 
The amount of the granulation liquid plays a key role in the pellet shaping. A 
higher liquid feed rate is preferred in the pelletization process. 
Keywords: enalapril-maleate, hydrochlorothiazide, multiparticulate matrix 
system, extrusion, spheronization, pellets  
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Introduction 
Enalapril-maleate is an ACE (angiotensin converting enzyme) inhibitor agent used in 
the treatment of hypertension. It reduces RAS (renin-angiotensin system) activity in 
the body, and has cardioprotective and renal-protective effects [1]. It is also used to treat 
congestive heart failure in adults. This API belongs to Class III of the Biopharmaceutics 
Classification System (BCS), so it has low permeability and high solubility. The 
absorption is limited by the permeation rate but the drug dissolves fast. The side effects 
of the API include allergic reactions, high potassium blood level (hyperkalaemia), 
dizziness, abdominal pain. To reduce these side effects, enalapril-maleate is often 
combined with diuretics, which reduces the potassium level in blood. 
Hydrochlorothiazide is a thiazide diuretic medication often used to treat high 
blood pressure. This API belongs to BCS Class IV, it has low permeability and low 
solubility. Those compounds have poor bioavailability. Usually they are not well 
absorbed over the intestinal mucosa and a high variability is expected. 
This work focused on the extrusion-spheronization process. The process of 
extrusion is applied in the pharmaceutical industry to manufacture many types of 
dosage forms. The strands of extrudates must not adhere to each other, and must exhibit 
such plasticity that the shape imposed by the die is maintained. In case of 
spheronization, under ideal circumstances, almost sphere-shaped particles are obtained. 
Drying follows spheronization. 
Microcrystalline cellulose (MCC) may be regarded as the standard and the most 
commonly used matrix former material in pellet preparation with extrusion [2-4]. It has 
plastic properties, thus it provides the cohesiveness of the wetted mass, which is suitable 
for extrusion and spheronization. MCC has a large surface area and high internal 
porosity, therefore it introduces the liquid into the matrix. Furthermore, in consequence 
JU
ST
 AC
CE
PT
ED
of its large surface area and high internal porosity, it is able to absorb and retain a large 
quantity of water thereby facilitating extrusion, improving the wetted mass plasticity 
and enhancing spheronization [5-8]. Moreover, the control of the movement of water 
through the plastic mass prevents phase separation during extrusion or spheronization. 
In order to decrease the amount of the used MCC, other pharmaceutical excipients are 
added and can achieve modified drug release, e.g. hydroxypropyl methylcellulose 
(HPMC) and hydroxyethyl cellulose (HEC) [9], ethylcellulose (EC) [7, 10], or К-
carrageenan [11, 12]. 
EC is an ideal polymer for the formation of products allowing modified drug 
release. It is insoluble at any pH level that occurs in the living organism, but in the 
presence of gastric juice it undergoes swelling. It is then permeable for water and 
permits extended drug release. 
This makes it suitable to improve patient compliance with the use of 
preparations administered once/twice daily [13]. A small number of ethylcellulose 
polymers have been approved for general pharmaceutical application (Ethocel 4, 
Ethocel 10, Ethocel 45 etc.), which only differ in the length of polymer chains, and in 
the rate of dissolution and the viscosity of their solution [14, 15] and are used in 
extended release solid dosage formulations. These ethylcelluloses are usually used as 
coating materials in the preparation of multiparticulate dosage forms [16, 17], but in 
recent studies EC is also used as matrix former excipient, especially in hot-melt 
extrusion processes, due to its excellent thermoplastic properties [18]. The application 
of EC in wet extrusion processes is limited, since the polymer has considerable elastic 
properties, but can be successfully used as matrix former in combination with some 
plasticizing agents [19, 20]. Mallipeddi et al. used the potential of coarse ethylcellulose 
(CPEC) and fine particle ethylcellulose (FPEC) as diluent with high molecular weight 
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polyethylene oxide (PEO), which was used as an extrusion aid and a binder [19, 20]. 
Their results have shown that water is sufficient to prepare a wet granulation product 
when using FPEC. MCC was included in their formulations to contribute its plasticity to 
the wetted mass during extrusion and to the extrudate during spheronization. 
In this work FPEC was used as matrix former, MCC as pelletization aid and 
deionised water with ethanol and TEC as granulation liquid. 
The present study is focusing on the optimization of the mechanical properties 
of EC-MCC sustained release matrix pellets, to understand the effect of the incorporated 
APIs with different solubility and particle size on the texture and mechanics of these 
systems. 
Materials and methods 
Materials 
Enalapril-maleate (EM) and hydrochlorothiazide (HCT) (Richter Gedeon Ltd., 
Budapest, Hungary) were applied as active pharmaceutical ingredient (API). Ethocel 
Standard 10 FP Premium (Colorcon Ltd. Dartford. England) was used as matrix former 
and MCC type 101 (Avicel 101, FMC Corporation, Philadelphia, USA) as 
pharmaceutical excipient (pelletization aid). A mixture from 1% triethyl-citrate (TEC), 
in an aqueous ethanol solution 96% (V/V) and deionised water were used as granulation 
liquid.  JU
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Methods 
Experimental plan 
The study dealt with the effect of 3 process parameters – spheronization time (x1), the 
liquid feed rate (x2), and the speed of the friction plate (x3) – on the pellet properties 
(shape, tensile strength, breaking force). Mixed 2 and 3 level
 
factorial design was 
applied to optimize the process parameters and the best composition for the 
experiments. We examined the liquid feed rate (x2) and the speed of the friction plate 
(x3) on 3 levels, while the effect of spheronization time on 2 levels. These dependent 
variables influenced the properties of the pellets. Statistica for Windows 11 AGA 
(Statsoft. Inc. Tulsa. USA) software was applied to determine the effects of the factors. 
 
Preparation of pellets 
1500 grams of powder mixture was prepared from 20% of API (enalapril-maleate or 
hydrochlorothiazide), 30% of ethylcellulose and 50% of microcrystalline cellulose. 
The powders were combined in a laboratory-scale blender (LM40, Bohle, 
Ennigerloh, Germany) for 10 min at 25 rpm and then transferred into the gravimetric 
powder feeder (KT 20, K-Tron Soder, Lenzhard, Switzerland) of the extruder. The 
twin-screw extruder (Mikro 27GL-28D, Leistritz, Nuremberg, Germany) was equipped 
with an axial screen with 23 dies of 1 mm diameter and 5 mm length. The extrusion 
took place at a constant screw speed of 100 rpm, a powder feed rate of 33 g/min and a 
liquid feed rate according to the experimental plan. Deionised water (89%) and 96% 
ethanol (10%) with TEC (1%) were used as granulation liquid supplied by a membrane 
pump. Batches of 40 g resultant strands of extrudates were collected and spheronized in 
a spheronizer (Caleva 120, Sturminster Newton, UK) according to the design of 
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experiments. The particles were dried in a fluid bed apparatus (GPCG 1.1., Glatt, 
Dresden, Germany) for 20 min with an inlet air temperature of 60°C. 
 
Image Analyzer 
The shape of the pellets was studied with image analysis using a system consisting of a 
stereo microscope (Leica MZ 75, Cambridge, UK), a ringlight with cold light source 
(Leica KL 1500, Cambridge, UK), a digital camera (Leica CS 300 F, Cambridge, UK), 
and an image analyzing software (Qwin, Leica, Cambridge, UK). In case of APIs, the 
particle size was analysed with the use of SEM images by ImageJ 1.46r (National 
Institute of Health, USA, http://imagej.nih.gov) software. 
The images of at least 500 pellets of each sample at a suitable magnification 
were translated into binary images. Contacting pellets were separated by a software 
algorithm. For each pellet, 36 Feret diameters were determined and also used to 
calculate the mean Feret diameter. The ratio of the maximum Feret diameter and the 
Feret diameter perpendicular to the maximum Feret diameter is used as the aspect ratio 
(AR). The pellet size and shape were characterized by the mean Feret diameter, aspect 
ratio and 10 % interval, respectively (Eq.1) 
 𝑑 =
dF
dF50
 (Eq.1.) 
with the dimensionless diameter (d), mean Feret diameter (dF) and median of all mean 
Feret diameters (dF50). 
The roundness of the particles is calculated with the following equation (Eq.2): 
 ○= 4
A
πdFmax
2 (Eq.2.) 
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where ○ is the roundness of the particles, A is the area, and dFmax is the maximal Feret 
diameter. 
The distribution of the particle size is characterized by the fraction of the 
particles in the interval 0.9 < d < 1.1. The size distribution is characterized as good if 
the fraction of the 10 % interval exceeds 50% and as excellent if it exceeds 75%. 
 
Scanning electron microscope 
The surfaces and the structures were tested with a scanning electron microscope (SEM) 
(Hitachi S4700, Hitachi Scientific Instruments Ltd., Tokyo, Japan). A sputter coating 
unit (Polaron E5100, VG Microtech, UK) was used to charge the surfaces for the SEM 
measurements. The air pressure during the analyses was 1.3-13 mPa. 
 
Mechanical properties of pellets 
The breaking strength of 40 pellets was tested. The strength tester and the software were 
developed in our institute in Szeged. The technical parameters are as follows: range of 
measurement: 0-200 N, rate of displacement: 20 mm/min, registering output: 0-500 mV, 
force sensor: Unicell load cell (C9B 20 kN cell). By changing the pressure jowl (stamp) 
and the sample holder, the equipment is appropriate for the measurement of the 
crushing force (F) of pellets. The breaking strength (hardness) value is given by the 
force of the last peak of the force-time plot, corresponding to the complete breaking of 
the pellet.  
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Results and discussion 
Both active ingredients (APIs) have tabular crystal habit (Fig. 1) and heterodisperse size 
distribution (Table 1). The most considerable difference between the APIs is particle 
size. EM crystals are tenfold bigger than hydrochlorothiazide particles. A further 
difference is that whilst EM crystals are well-developed and sometimes covered by tiny, 
irregularly-shaped crystal grains (Fig. 1a), the edges and corners of the HCT crystals are 
rounded (Fig. 1d, e, f). The sticking of smaller particles on the surface of larger 
crystals - which suggests a strong cohesion between them - is also characteristic of 
HCT. That is why a number of irregular looking crystals are visible at small 
magnifications (Fig. 1b), with the presence of some big crystal agglomerates. It is well 
visible at higher magnifications (Fig. 1d, e, f) that the smaller particles are irregular 
aggregates of few tabular crystals, while bigger agglomerates are formed from 
undeveloped particles (Fig. 1c) and behave as individual units in the product.  
As it can be seen, except for the solubility and particle size, the general physical 
properties of the APIs are similar, and their mechanical behaviour during the extrusion-
spheronization process is expected to be similar, too. 
Pellets are defined as spherical, free flowing granules with a narrow size 
distribution, typically varying between 0.50 and 1.50 mm. All experimental settings 
resulted in pellets for both formulations with a mean average Feret diameter from 1.0 to 
1.5 mm (Table 2). The shorter spheronization time results in larger size particles. The 
reason for this phenomenon is that the particles do not have enough time to get a 
rounded shape, and thus “bone” shaped particles are formed during spheronization, the 
particle size of which is larger as well. The 10% interval describes the fraction of pellets 
within the interval 0.9-1.1 of the dimensionless diameter. The fraction in the 10% 
interval was in the 50-94% range in case of pellets with enalapril-maleate and in the 52-
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97% range in case of hydrochlorothiazide pellets. Thus all size distributions can be 
regarded as good. 
The most common parameter to describe the shape of pellets is the aspect ratio. 
Pellets of a mean aspect ratio above 1.2 were regarded insufficient [21]. 
The results show that the aspect ratio and the other shape parameters are the 
worst if the process parameters are at minimum level (Fig. 2a), but spherical-shaped 
pellets may be gained with some optimization. The aspect ratio was close to 1 in the 
case of Samples 16-18 for both APIs, where the liquid feed rate and the spheronization 
time is on a higher level (Fig. 2b). 
The effect of the different process parameters as factors was studied on the basis 
of a mixed (2 and 3) level full factorial design. The different experimental settings and 
the corresponding physical properties are displayed in Table 2. 
The response surfaces of the various optimization parameters may be described 
with the following general equation 3.: 
 y = b0 + b1x1 + b2x2 +b22x2
2 
+ b3x3 +b33x3
2
+ b12x1x2 + b13x1x3+b23x2x3 (Eq.3.) 
(where x1:spheronization time, x2:liquid feed rate, x3: spheronization speed) 
The regression coefficients and statistical results are displayed in Table 3, significant 
factors are highlighted with red colour. 
It can be seen from the statistical results that the aspect ratio is significantly 
influenced by all three factors, within standard 95% CI (p<0.05) and the liquid feed rate 
(x2) has the most considerable effect, while spheronization time (x1) has the smallest, 
for both APIs. The higher factor values resulted in smaller aspect ratio values and also 
in the formation of sphere-shaped pellets in both cases. Nevertheless, a considerable 
difference between the two APIs is that the aspect ratio of HCT pellets decreases 
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linearly with the increment of the liquid addition rate, while EM exhibits a nonlinear 
dependence on this factor (Fig. 3a, b). The explanation of this difference may be the 
different solubility of the APIs, which exerts considerable effect on the pellet texture 
through the influencing of the distribution of the water inside the wet mass. 
The structural differences of the samples are well visible on the cross-sectional 
scanning electron micrographs (Fig. 4). Although the low magnification images show 
compact spongiform texture for all investigated samples, the pellets with higher aspect 
ratio (Fig. 4a, b) exhibit slightly higher apparent porosity, while pellets with low AR 
show a dense texture, despite the hole in their centre (Fig. 4e, f). The increasing 
magnification reveals some differences of the sponge-like texture of the EC-MCC 
matrices. Besides the smooth surface of the embedded EM crystals surrounded with 
fibriform, filamentous, crumpled MCC grains (black arrows), numerous rounded EC 
particles (red arrows) connected to them may be clearly identified in EM 1 pellets (Fig. 
4c). The cross section of HCT-1 pellets shows more uneven surface, but the general 
matrix texture is similar and the round EC grains (red arrows) may be identified (Fig. 
4d). It can be assumed that the smaller crystals are bound to the matrix formers with a 
greater force. The cross-sectional picture shows that the matrix-former breaks up in a 
filamentous way, so cohesion was strong there. The breaking surface of the EM-18 and 
HCT-18 pellets (Fig. 4e, f) is generally splintered, which indicates strong cohesion 
between the particles. Numerous fibrous ruptures (white arrows) may be identified on 
the breaking surface, which can be due to the elastic deformation of the EC grains 
during the breaking process (Fig. 4g, h). Consequently, intact, rounded EC grains 
cannot be identified in EM 18 and HCT 18 pellets. This indicates that the high liquid 
feed rate induced structural (morphological) changes in the EC grains, and the better 
deformation of these samples may be due to the plasticizing effect of the water. 
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If the better soluble EM bonds more water, that could be the reason for the 
nonlinear relation between the aspect ratio and liquid addition rate in these pellets. 
The differences of the two APIs are also visible if we take into consideration the 
interactions between the factors. In the case of EM pellets, the interaction of the 
spheronization speed and the liquid feed rate is significant, and the other interactions 
have a negligible effect. In contrast, the interaction of the liquid feed rate with the two 
spheronization parameters has equal weight for HCT pellets. In general, the 
spheronization speed has almost no effect on the shape of the particles at low liquid feed 
rates, which also supports the negative effect of the unplasticized EC grains on this 
parameter. 
The different texture and embedding mechanism of the API crystals also have a 
significant effect on the mechanical properties (hardness) of pellets. The general 
breaking process of the pellets is displayed in Figure 5. Each section of the process is 
marked by a coloured line. The deformation of a pellet starts with a short period of 
elastic deformation. The green line shows the maximum value of this period. In the 
second stage, a short period of viscoelastic deformation occurs, which can be due to the 
presence and elastic properties of EC (from green line to black). The third stage 
involves the first cracks in the pellet (from black line to purple), influencing only the 
microstructure without any sign of macroscopic changes. In the fourth stage, as pressure 
increases, a structure change develops in the pellet (from purple line to red). Every solid 
body-bridge within the pellet will crack in this stage. In the end (from the red line), the 
final deformation of the pellet occurs. 
Cespi et al. states [22] that various authors adopted different approaches to 
assume the correspondence between a given peak of such a complicated deformation 
procedure and the real crushing strength value. In some cases, the last one was chosen, 
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whereas in other cases the highest one and yet in other works the first peak giving a 
preset drop of force was taken into account. In the present case the breaking hardness 
value is given by the force corresponding to the last peak of the force-time plot, since 
this was the starting point of the macroscopic deformation of the pellets. 
The maximal breaking strength of HCT pellets is lower in comparison with the 
corresponding EM ones (Table 2), possibly due to the different embedding and 
distribution of API particles within the EC-MCC matrix. Furthermore, the statistical 
analysis revealed that although the pellet hardness is influenced most significantly by 
spheronization time, within 95% CI (p<0.05) for both APIs, but amongst the other 
factors the liquid feed rate is significant for the EM and the spheronization speed for the 
HCT pellets (Table 3). This indicates the different behaviour of the various textures, 
which may be related to the different number and arrangement of solid bridges inside 
the matrix. The greater hardness of EM pellets is possibly related to the greater amount 
of dissolved particles due to the better solubility of the API, which results in more 
intense solid bridge formation after the drying and recrystallization of these particles. 
 
Conclusions 
It was confirmed that the assurance of required pellet shape is problematic due to the 
elastic properties of EC. The use of EC-MCC mixture provides better process yield in 
comparison with the EC-MCC-PEO mixture applied by Mallipeddi et. al, since there is 
no hydrogel formation. 
The amount of the granulation liquid plays a key role in the pellet shaping. The 
higher liquid addition rate induced morphological changes in the EC grains. At the same 
time the wet mass had a higher plasticity, which resulted in better densification and 
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deformability within the studied factor space. 
The solubility of the applied API also has a considerable effect on the pellet 
properties. As it was expected, similar shape parameters may be ensured using lower 
liquid addition rates if well soluble API is granulated. Nevertheless, the decrease of the 
liquid addition rate below a certain level has a negative effect on the liquid distribution, 
which results in a nonlinear relationship between liquid addition rate and aspect ratio. 
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Legend to Figures 
 
Figure 1. SEM picture of EM (a), and HCT in magnification 200x (b) 500x 
(aggregate) (c), 500 x (individual crystals) (d), 1000x (e) and 2000x (f) 
Figure 2. SEM pictures of insufficient (a) and well-shaped (b) pellets 
Figure 3. Response surface on the aspect ratio of EM (a) and HCT (b), and hardness 
of EM (c) and HCT (d) pellets 
Figure 4. Scanning electron micrographs of the cross sections of various pellets (EM 
1 100x (a), HCT 1 100x (b), EM 1 1000x (c), HCT 1 1000x (d), EM 18 
100x (e), HCT 18 100x (f), EM 18 1000x (g), HCT 18 1000x (h)) 
Figure 5. General deformation process of the studied pellets  
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Table 1  Morphological parameters of APIs 
 Enalapril-maleate Hydrochlorothiazide 
Aspect ratio 1.866 1.829 
Roundness 0.595 0.63 
Mean Feret diameter (µm) 67.4 (±43.84) 5.57 (±3.96) 
Aqueous solubility 
(mg/ml) 
25 0.722 
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Table 2  Properties of EM and HCT-containing pellets as a function of the production 
parameters 
Samples 
X1 
Spher. 
time 
(min) 
X2 
Liquid 
feed rate 
(g/min) 
(EM/HCT) 
X3 
Spher. 
speed 
(rpm) 
Mean Feret  
diameter 
(mm) 
10% 
interval (%) 
Aspect ratio  
Hardness 
(N) 
EM HCT EM HCT EM HCT EM HCT 
1. 2.5 25/26.3 1000 1.31 
(±0.06) 
1.27 
(± 0.12) 
52.8 52.2 1.60 1.58 17.3 12.0 
2. 2.5 25/26.3 1250 1.21 
(± 0.08) 
1.46 
(± 0.17) 
62.4 70.0 1.40 1.52 12.6 13.0 
3. 2.5 25/26.3 1500 1.13 
(± 0,09) 
1.15 
(± 0.09) 
49.5 56.2 1.25 1.33 14.7 12.7 
4. 2.5 27/28.5 1000 1.25 
(± 0.11) 
1.28 
(± 0.11) 
50.8 59.6 1.57 1.55 16.2 11.3 
5. 2.5 27/28.5 1250 1.20 
(± 0.08) 
1.22 
(± 0.11) 
73.8 60.6 1.50 1.41 13.7 13.5 
6. 2.5 27/28.5 1500 1.23 
(± 0.10) 
1.16 
(± 0.07) 
76.8 62.2 1.36 1.32 15.4 13.9 
7. 2.5 29/30.3 1000 1.22 
(± 0.02) 
1.22 
(± 0.08) 
82.6 66.4 1.24 1.44 10.4 9.1 
8. 2.5 29/30.3 1250 1.25 
(± 0.11) 
1.17 
(± 0.13) 
79.6 77.6 1.10 1.27 11.2 10.4 
9. 2.5 29/30.3 1500 1.12 
(± 0.14) 
1.16 
(± 0.14) 
85.0 73.4 1.10 1.16 12.3 15.4 
10. 10 25/26.3 1000 1.22 
(± 0.07) 
1.22 
(± 0.10) 
78.2 63.4 1.49 1.54 16.3 15.4 
11. 10 25/26.3 1250 1.17 
(± 0.07) 
1.14 
(± 0.08) 
93.6 82.6 1.30 1.36 19.3 19.5 
12. 10 25/26.3 1500 1.10 
(± 0.11) 
1.01 
(± 0.07) 
91.4 82.6 1.15 1.24 19.5 19.5 
13. 10 27/28.5 1000 1.23 
(± 0.08) 
1.16 
(± 0.11) 
87.2 85.2 1.54 1.30 15.2 15.6 
14. 10 27/28.5 1250 1.17 
(± 0.14) 
1.13 
(± 0.10) 
92.6 86.4 1.31 1.25 18.1 14.2 
15. 10 27/28.5 1500 1.11 
(± 0.12) 
1.03 
(± 0.09) 
93.0 75.4 1.15 1.11 18.0 20.9 
16. 10 29/30.3 1000 1.21 
(± 0.09) 
1.19 
(± 0.13) 
90.4 97.0 1.07 1.08 15.1 14.3 
17. 10 29/30.3 1250 1.18 
(± 0.08) 
1.10 
(± 0.12) 
84.0 96.8 1.06 1.05 19.1 14.0 
18. 10 29/30.3 1500 1.18 
(± 0.07) 
1.09 
(± 0.10) 
82.0 95.6 1.07 1.06 15.1 14.0 
  
JU
ST
 AC
CE
PT
ED
Table 3  Effects of factors on the aspect ratio (AR) and breaking hardness 
 AR Hardness 
 EM HCT EM HCT 
R
2
 0.9215 0.9525 0.7070 0.7996 
MS Residual 0.0047 0.0023 4.1575 3.6379 
b0 1.283 1.285 15.515 14.370 
b1 -0.047 -0.080 1.764 2.002 
b2 -0.129 -0.117 -1.373 -1.237 
b22 0.071 0.007 0.434 0.413 
b3 -0.107 -0.099 0.381 1.561 
b33 -0.004 0.005 0.104 -0.204 
b1b2 0.008 -0.031 0.398 -0.782 
b1b3 -0.014 0.014 0.623 -0.039 
b2b3 0.069 0.030 0.154 0.153 
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